| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_527da4e3fc71c3376348643ca4472333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-22 |
| filingDate |
2007-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70035a0573d3bbad974201e66db5cb92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6eb3327390976525918935531a9932b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23af14f00a51dea739e652c78dc0a24e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ef53155815bad127fbe6b6a082323cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_253d3140272e98be09b3cfa71cf16889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22d0d46654a3986fe354e44ad29ed009 |
| publicationDate |
2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2450019-C2 |
| titleOfInvention |
Neisseria meningitidis polypeptides |
| abstract |
FIELD: medicine. n SUBSTANCE: polypeptide (versions) immunogenic with respect to meningococcal infections contains: an amino acid sequence at least 90 % identical to a sequence presented in the description (SEQ ID NO: 32), or said amino acid sequence, or a fragment of 80 sequenced amino acids of said sequence. What is described is an antibody which contacts with the polypeptide under the invention and which may be used as a drug. What is described is nucleic acid of the preset structure which codes the polypeptide or its versions and which may be used for treating or preventing a disease and/or an infection caused by Neisseria meningitides. The invention provides additional polypeptides applicable in advanced vaccines for preventing and/or treating meningococcal meningitis. The peptides can also find application in diagnosing of the disease and as targets of antibiotics. n EFFECT: higher clinical effectiveness for meningococcal meningitis. n 19 cl, 2 tbl |
| priorityDate |
2006-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |